Herbas VPB

Print
EN | LT
LT - Deguonimi įsodrintų cholesterolio sulfatų (OCS) naudojimas inkstų disfunkcijai gydyti
EN - USE OF OXYGENATED CHOLESTEROL SULFATES (OCS) FOR THE TREATMENT OF KIDNEY DYSFUNCTION

Legal status

Patent lapsed (non-payment of fees)

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 31/575 (2006.01)
A61K 31/56 (2006.01)
A61P 43/00 (2006.01)
A61P 1/16 (2006.01)
A61K 31/568 (2006.01)
A61K 35/12 (2015.01)
A61P 13/12 (2006.01)
European patent
(11) Number of the document 3086793
(13) Kind of document T
(96) European patent application number 14874617.5
Date of filing the European patent application 2014-12-23
(97) Date of publication of the European application 2016-11-02
(45) Date of publication and mention of the grant of the patent 2022-05-11
(46) Date of publication of the claims translation 2022-08-25
PCT application
(86) Number PCT/US2014/072128
Date 2014-12-23
PCT application publication
(87) Number WO 2015/100312
Date 2015-07-02
Priority applications
(30) Number Date Country code
201361920617 P 2013-12-24 US
Inventors
(72)
REN, Shunlin , US
THEEUWES, Felix , US
BROWN, James E. , US
LIN, WeiQi , US
Grantee
(73) Virginia Commonwealth University , 800 East Leigh Street Suite 3000, Richmond, VA 23298, US
The United States Government as Represented by the Department of Veterans Affairs , 810 Vermont Avenue, N.W., Washington, DC 20420, US
Durect Corporation , 10260 Bubb Road, Cupertino, CA 95014, US
Attorney or representative
(74) Reda ŽABOLIENĖ, METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius, LT
Title
(54) Deguonimi įsodrintų cholesterolio sulfatų (OCS) naudojimas inkstų disfunkcijai gydyti
  USE OF OXYGENATED CHOLESTEROL SULFATES (OCS) FOR THE TREATMENT OF KIDNEY DYSFUNCTION
Last renewal fee
Payment date Validity (years) Amount
2023-12-04 10 231.00 EUR
Legal status
Patent lapsed (non-payment of fees)
Invalidation date 2024-12-23